Form D · Other Health Care
Veritract, Inc.
Salt Lake City, UT · CIK 0001517278
Offering snapshot reported Apr 5, 2011 · SEC filing
- Reported sold
- $820K Offering amount: $1M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Mar 23, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 5, 2011 | Initial | $819,500 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-157808
Source: Form D, filed Apr 5, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Troy D'ambrosio | Director |
| John Fang | Director, Executive |
| Barry Hanover | Director |
| Ned Weinshenker | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1682 East Yale Avenue
Salt Lake City, UT, 84105
Salt Lake City, UT, 84105